1. Home
  2. FSP vs XBIT Comparison

FSP vs XBIT Comparison

Compare FSP & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

N/A

Current Price

$0.65

Market Cap

72.4M

Sector

Real Estate

ML Signal

N/A

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.37

Market Cap

74.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSP
XBIT
Founded
1981
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Pharmaceuticals and Biotechnology
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.4M
74.4M
IPO Year
2001
2015

Fundamental Metrics

Financial Performance
Metric
FSP
XBIT
Price
$0.65
$2.37
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
577.8K
25.7K
Earning Date
04-28-2026
05-08-2026
Dividend Yield
6.34%
N/A
EPS Growth
15.69
N/A
EPS
N/A
N/A
Revenue
$107,162,000.00
N/A
Revenue This Year
$17.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$2.09
52 Week High
$1.82
$3.61

Technical Indicators

Market Signals
Indicator
FSP
XBIT
Relative Strength Index (RSI) 60.44 40.35
Support Level $0.58 $2.35
Resistance Level $0.70 $2.41
Average True Range (ATR) 0.06 0.05
MACD 0.02 -0.00
Stochastic Oscillator 62.86 13.60

Price Performance

Historical Comparison
FSP
XBIT

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

Share on Social Networks: